Literature DB >> 30056006

Nonlinear associations between dietary exposures to perfluorooctanoic acid (PFOA) or perfluorooctane sulfonate (PFOS) and type 2 diabetes risk in women: Findings from the E3N cohort study.

Francesca Romana Mancini1, Kalina Rajaobelina2, Delphine Praud3, Courtney Dow2, Jean Philippe Antignac4, Marina Kvaskoff2, Gianluca Severi2, Fabrice Bonnet5, Marie-Christine Boutron-Ruault2, Guy Fagherazzi2.   

Abstract

The incidence of type 2 diabetes (T2D) is steadily rising worldwide since the past 30 years. There is increasing interest in understanding the contribution of exposure to endocrine disrupting chemicals (EDCs) to T2D trend. Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) are stable, persistent, and bioaccumulative synthetic compounds, suspected to act as EDCs and for which the diet is the main route of exposure. We investigated associations between estimated dietary exposure to PFOS and PFOA and the risk of T2D in the large E3N prospective cohort study. Among 71 270 women included in this study, 2680 cases of incident type 2 diabetes were validated during follow-up (1993-2012). Dietary exposure was estimated combining dietary consumption data collected in E3N and food contamination data provided by ANSES in the 2nd French Total Diet Study. The estimated mean dietary exposure to PFOS and PFOA was 0.50 ng/kg body weight/day and 0.86 ng/kg body weight/day respectively. An inverse U-shape association was found when considering PFOA and T2D: women in the 4th, 5th, and 6th decile groups had a HR [95%CI] of 1.21 [1.06-1.46], 1.35 [1.15-1.59], and 1.33 [1.05-1.41], respectively, when compared to women of the 1st decile group, while the other decile groups were not associated to the risk of T2D. The positive association had the strongest effect size for non-obese women (body mass index (BMI) ≤25 kg/m2). No association was found between dietary exposure to PFOS and T2D, except when considering only women with BMI≤25 kg/m2, in which a positive nonlinear association was observed (HR [95%CI] = 1.46 [1.09-1.96], 1.52 [1.09-2.11], and 1.44 [1.01-2.06] for the 6th, 8th, and 9th decile groups respectively). This is the first study to evaluate the association between dietary exposure to PFOA and PFOS and the risk of developing T2D in a large observational study with over 15 years of follow-up. The present study highlights the importance of studying the effects of EDCs in large epidemiological studies including not occupationally exposed populations, as well as the importance of considering exposure to PFOS and PFOA as a relevant risk factor for T2D.
Copyright © 2018. Published by Elsevier GmbH.

Entities:  

Keywords:  Dietary exposure; Perfluorooctane sulfonate (PFOS); Perfluorooctanoic acid (PFOA); Type 2 diabetes

Mesh:

Substances:

Year:  2018        PMID: 30056006     DOI: 10.1016/j.ijheh.2018.07.007

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  12 in total

1.  Per- and Polyfluoroalkyl Substances and Obesity, Type 2 Diabetes and Non-alcoholic Fatty Liver Disease: A Review of Epidemiologic Findings.

Authors:  Weipeng Qi; John M Clark; Alicia R Timme-Laragy; Yeonhwa Park
Journal:  Toxicol Environ Chem       Date:  2020-05-22       Impact factor: 1.437

2.  Associations of Perfluoroalkyl and Polyfluoroalkyl Substances With Incident Diabetes and Microvascular Disease.

Authors:  Andres Cardenas; Marie-France Hivert; Diane R Gold; Russ Hauser; Ken P Kleinman; Pi-I D Lin; Abby F Fleisch; Antonia M Calafat; Xiaoyun Ye; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Diabetes Care       Date:  2019-07-11       Impact factor: 19.112

3.  Dietary inflammatory index and type 2 diabetes risk in a prospective cohort of 70,991 women followed for 20 years: the mediating role of BMI.

Authors:  Nasser Laouali; Francesca Romana Mancini; Mariem Hajji-Louati; Douae El Fatouhi; Beverley Balkau; Marie-Christine Boutron-Ruault; Fabrice Bonnet; Guy Fagherazzi
Journal:  Diabetologia       Date:  2019-08-09       Impact factor: 10.122

Review 4.  Association between per- and polyfluoroalkyl substances exposure and risk of diabetes: a systematic review and meta-analysis.

Authors:  Si-Yu Gui; Jian-Chao Qiao; Ke-Xin Xu; Ze-Lian Li; Yue-Nan Chen; Ke-Jia Wu; Zheng-Xuan Jiang; Cheng-Yang Hu
Journal:  J Expo Sci Environ Epidemiol       Date:  2022-08-15       Impact factor: 6.371

5.  Multi- and Transgenerational Effects of Developmental Exposure to Environmental Levels of PFAS and PFAS Mixture in Zebrafish (Danio rerio).

Authors:  Alex Haimbaugh; Chia-Chen Wu; Camille Akemann; Danielle N Meyer; Mackenzie Connell; Mohammad Abdi; Aicha Khalaf; Destiny Johnson; Tracie R Baker
Journal:  Toxics       Date:  2022-06-18

6.  Life-course Exposure to Perfluoroalkyl Substances in Relation to Markers of Glucose Homeostasis in Early Adulthood.

Authors:  Damaskini Valvi; Kurt Højlund; Brent A Coull; Flemming Nielsen; Pal Weihe; Philippe Grandjean
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 5.958

7.  Per- and polyfluoroalkyl substance plasma concentrations and metabolomic markers of type 2 diabetes in the Diabetes Prevention Program trial.

Authors:  Susanna D Mitro; Jinxi Liu; Lindsay M Jaacks; Abby F Fleisch; Paige L Williams; William C Knowler; Blandine Laferrère; Wei Perng; George A Bray; Amisha Wallia; Marie-France Hivert; Emily Oken; Tamarra M James-Todd; Marinella Temprosa
Journal:  Int J Hyg Environ Health       Date:  2020-12-18       Impact factor: 5.840

Review 8.  Exposure to Perfluoroalkyl Chemicals and Cardiovascular Disease: Experimental and Epidemiological Evidence.

Authors:  Alessandra Meneguzzi; Cristiano Fava; Marco Castelli; Pietro Minuz
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-09       Impact factor: 5.555

Review 9.  Associations between Exposures to Perfluoroalkyl Substances and Diabetes, Hyperglycemia, or Insulin Resistance: A Scoping Review.

Authors:  Rachel Margolis; Karilyn E Sant
Journal:  J Xenobiot       Date:  2021-09-14

Review 10.  Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease.

Authors:  Julie Massart; Karima Begriche; Anne Corlu; Bernard Fromenty
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.